-
Imatinib (STI571) Workflow for Kinase Assays
2026-09-01
Imatinib (STI571) provides a practical perturbation tool for dissecting PDGF receptor, c-Kit, and Abl signaling across biochemical, cellular, and translational models. This workflow connects phospho-protein measurements with proliferation, migration, and remodeling phenotypes while highlighting controls that improve reproducibility.
-
gamma-Glu-Cys (γ-Glu-Cys) Lab Guide
2026-09-01
gamma-Glu-Cys (γ-Glu-Cys) provides a defined intermediate for glutathione metabolism research, glutathione synthetase enzyme assays, and selected phytochelin-related workflows. It is intended for controlled scientific research with freshly prepared solutions, not for diagnostic, clinical, medical, or therapeutic use.
-
Lipo3K Transfection Reagent for Drug-Resistance Assays
2026-08-31
Turn a mechanistic drug-resistance hypothesis into a controlled transfection workflow using DNA, siRNA, or mRNA delivery. Lipo3K combines high delivery efficiency with low toxicity, supporting transporter perturbation, co-transfection, and direct collection for downstream analysis.
-
Bazedoxifene for Postmenopausal Osteoporosis
2026-08-31
The 2019 review evaluates Bazedoxifene as a third-generation selective estrogen receptor modulator using randomized phase III evidence extending to seven years. Its main conclusion is clinically balanced: Bazedoxifene provides vertebral-fracture protection and modest lumbar-spine bone mineral density enhancement, but its broader advantages over established antiresorptive therapies remain limited.
-
JNJ-26854165: Beyond Viability Assays
2026-08-30
JNJ-26854165 (Serdemetan) is an HDM2 antagonist that can reveal how p53 pathway modulation separates growth arrest from cell death. This guide presents an endpoint-aware framework for cancer research, including assay design, compound handling, and interpretation of radiosensitization data.
-
pH-Responsive i-Motif ASO Prodrugs in MYCN Cells
2026-08-29
Zhang and colleagues developed hairpin antisense oligonucleotide prodrugs that use an i-motif as a pH-responsive structural switch. Systematic tuning of loop architecture and stem length identified R3-5 and R5-5 as promising in vitro constructs for MYCN silencing and apoptosis induction in SK-BE(2) cells.
-
From GTP Chemistry to Localized p21 mRNA Therapy
2026-08-28
Localized p21 mRNA–LNP therapy illustrates how transient RNA expression can address tumor-suppressor loss while limiting systemic exposure. This thought-leadership article connects that translational strategy to upstream nucleotide control, showing how GTP quality, handling, and workflow design can influence reproducibility without overstating what a reagent alone can achieve.
-
Camostat Mesilate for Reliable Cell Assays
2026-08-28
Learn how Camostat Mesilate (SKU B2082) can improve interpretation of cell viability, proliferation, and cytotoxicity experiments by separating protease-pathway effects from nonspecific injury. This scenario-based guide covers mechanism, formulation, dose design, controls, data interpretation, and practical vendor-selection criteria.
-
Pepstatin A: Reading Protease-Dependent Trafficking
2026-08-27
Pepstatin A is an aspartic protease inhibitor for dissecting enzyme activity in viral protein processing, osteoclast biology, and protein-trafficking assays. This guide connects inhibitor choice with the deeper assay logic of ER quality control and receptor surface expression.
-
UK-5099 for Reliable Metabolic Assays
2026-08-27
Learn how UK-5099 (SKU A3899; PF-1005023) can help separate mitochondrial metabolic effects from nonspecific loss of viability in cell, insulinoma, and immunometabolic workflows. This scenario-based guide covers assay design, formulation, controls, interpretation, and practical product-selection criteria.
-
Cre Recombinase mRNA for Programmable Translation
2026-08-26
Transient Cre expression is becoming more valuable as mRNA delivery moves beyond liver-focused applications. This article connects m1Ψ and Cap 1 transcript design with EVMP-based extrahepatic delivery, showing how EZ Cap™ Cre mRNA (m1Ψ) can support rigorous gene editing, functional studies, and translational assay development while keeping payload performance distinct from delivery performance.
-
Pepstatin A in Lysosomal Protease Assays
2026-08-26
Pepstatin A is an aspartic protease inhibitor with applications spanning enzyme assays, viral protein processing research, and lysosome-linked cell death studies. This guide explains how to use it without confusing cathepsin D inhibition with the cathepsin B mechanism that drives necroptosis.
-
Position-3 Design of GnRH Antagonists
2026-08-25
The reference study examined how replacing the position-3 residue of degarelix with stereoisomeric 3-(2-methoxy-5-pyridyl)-alanine affects GnRH receptor antagonism and duration of action. Its findings show that the D-isomer retained strong in vitro potency, whereas the L-isomer was weaker, but neither analog preserved the parent compound’s prolonged in vivo activity.
-
gamma-Glu-Cys (γ-Glu-Cys): Workflow Guide
2026-08-25
gamma-Glu-Cys (γ-Glu-Cys) provides a defined substrate and pathway intermediate for glutathione synthetase enzyme assays, glutathione metabolism research, and selected peptide or plant workflows. Use it as a freshly prepared research reagent with controlled handling; it is not intended for diagnostic, clinical, or long-term solution-storage applications.
-
Nano-ZD Redirects Zoledronate to Innate Immunity
2026-08-24
This Cell Reports Medicine study develops nano-granulated zoledronate (Nano-ZD) to redirect a mevalonate-pathway modulator toward draining lymph-node innate immune cells. The formulation enhances vaccine and antitumor responses, while mechanistic data identify a mevalonate–CoQ–OXPHOS/pyrimidine axis that may guide immune-metabolic adjuvant design.